Neu5Gc alpha(2-3)Gal beta MP Glycoside>95.0%(HPLC)5mg

Objetivo de itrio 99,9% dia. 50,8 mm x espesor 3,18 mm 1 ud.

1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 250mg

3,5-Bis(trifluoromethyl)phenylacetonitrile, 98.0%, 5g

2-(Prop-2-en-1-yloxy)benzoic acid, 95%, 10g

2-Butanone, 4-[3-methoxy-4-(phenylmethoxy)phenyl]-, 98%, 1g

4-(2,5-Dimethoxy-phenyl)-2-oxo-2,3-dihydro-thiazole-5-carboxylic acid ethyl ester, 250mg

N-butyl-N-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide, 98.0%, 5g

3-Azetidinecarboxylic acid, 1-(3-bromo-2-pyridinyl)-, 100mg

4-(1-pyrrolidinylcarbonyl)piperidine nitrate, 95.0%, 5g

2,4-DICHLORO-5H,6H,7H,8H-PYRIDO[3,4-D]PYRIMIDIN-8-ONE, 95%, 1g

N-Boc-exo-3-Amino-8-azabicyclo[3.2.1]octane, 97.0%, 1g

2-(6-Fluoropyridin-2-yl)acetonitrile, 95+%, 100mg